13th World Congress on
Gynecology and Obstetrics

Dr. Jie Hu currently is an Associate Professor at the Ohio State University, College of Nursing, USA. Dr. Jie Hu earned her PhD degree from the University of Arizona, USA. She is a Fellow in the American Academy of Nursing. Dr. Hu served as a member of Global Advisory Group on Nursing and Midwifery of the World Health Organization from 1997-2001

Dr. Jie Hu’s area of research includes diabetes self-management intervention with focus on minority populations (Hispanics and Chinese); health-related quality of life in older adults with chronic diseases.

Dr. Lisa Eckenwiler is an Associate Professor of Philosophy in the Departments of Philosophy and Health Administration and Policy at George Mason University. Professor Eckenwiler earned her B.A. from the University of Wisconsin-Madison and her Ph.D. in philosophy with a concentration in bioethics from the University of Tennessee-Knoxville. Prior to joining the faculty at George Mason University Dr. Lisa Eckenwiler was Associate Professor of Philosophy and Co Director of the Institute for Ethics and Public Affairs at Old Dominion University. From 2002-2003, Dr. Lisa Eckenwiler served as Director for the Consortium to Examine Clinical Research Ethics at the Center for the Study of Medical Ethics and Humanities at Duke University.

Dr. Eckenwiler’s current research focuses on ethical issues at the intersection of long-term care, health worker migration, especially nurses and care workers, and global health inequitie

Dr. Levi Downs is the Chief Medical Officer of University of Minnesota Physicians and University of Minnesota Medical Center. Additionally, Dr. Downs is the Clinical Care Co-Director of the Deborah. E. Powell Center for Women's Health, A Nationally Designated Center of Excellence and is the Program Co-leader of the Women's Cancer Research Program. Dr. Downs is a board certified gynecologic oncologist. Dr. Downs received his medical degree in 1994 from the University of Pittsburgh School of Medicine and completed an obstetrics and gynecology internship and residency at the Magee-Women’s Hospital of the University of Pittsburgh Medical Center. He completed a gynecologic oncology fellowship at the University of Minnesota.

Dr. Downs’ research interests include HPV induced carcinogenesis, molecular therapeutics for cervical cancer and gynecologic oncology clinical trials.

Dr. Rasgon is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology in the Stanford School of Medicine. In addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Stanford Center for Neuroscience in Women's Health and Associate Dean of Academic Affairs for the School of Medicine. Dr. Rasgon obtained an M.D. from the U.S.S.R. in 1980, a Ph.D. in Reproductive Endocrinology in 1988 from the Central Institute of Postgraduate Medical Education, and a Ph.D. in Pathological Physiology from the Central Research Institute of General Pathology & Pathological Physiology Academy of Medical Sciences, Moscow, USSR. In addition, Dr. Rasgon was an NSRA Research Fellow at the Neuropsychiatric Institute, UCLA School of Medicine from 1995-1996, an Assistant Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Neuropsychiatric Institute and Hospital, and the Director of the UCLA Menopause-Related Mood Disorders Program, UCLA Neuropsychiatric Institute and Hospital.

Dr. Rasgon research focuses on the interaction between reproductive hormones and brain function. Research efforts of the lab are concentrated in two areas: (1) the reproductive endocrine status of women with affective disorders, and (2) the neurobiology of the effects of hormone therapy in aging women.

Dr. Marlene Shehata has received her PhD in Cellular and Molecular Medicine, specializing in Genetics of Cardiovascular Diseases from the University of Ottawa during the period of 2004-2010. Dr. Shehata is also a licensed Ontario Pharmacist practicing in South-western Ontario. Currently, Dr. Marlene Shehata is working as a Clinical Pharmacist Consultant in numerous academic hospitals, nursing homes and community pharmacies in South-western Ontario. She has successfully completed her Administrative responsibilities as a Manager for the Pharmacy and Clinical Services Department. She is currently the Editor-in-Chief of the Journal of Pharmacology Research, Associate Editor for the Journal of Eco-biotechnology and The Journal of Biotechnology Applications. She sits on the editorial boards of numerous journals including the African Journal of Biotechnology and Hypertension-Open Access. Dr. Shehata has authored 23 research articles, 2 book chapters and 24 abstracts. She is a member of the Canadian Hypertension Society, Canadian Cardiovascular Society, Ontario Pharmacists Association and Ontario College of Pharmacists. She is the 2011 recipient of the Certificate of Excellence by Hypertension Canada and the 2007 Horizon Award recipient by Memorial University of Newfoundland. She was awarded numerous other awards including the Pfizer Canada.

Dr. Marlene Shehata research interest include cellular and molecular medicine, genetics of cardiovascular diseases and pharmacology research.

Dr. Kahn is currently a Clinical Associate Professor of Surgery at Stanford University Medical Center, USA. Dr. Kahn has been recognized for excellence in teaching both throughout his training and as a member of the Plastic Surgery faculty at Stanford. Dr. Kahn went on to earn his medical degree at the Albany Medical College. In Albany, he received an award for outstanding academic achievement in surgery. Dr. Kahn then completed a five-year General Surgery residency at the University of Medicine and Dentistry of New Jersey in Newark, serving as Chief Resident in his final year. Dr. Kahn pursued Plastic Surgery fellowship training at the University of California, San Francisco. Dr. Kahn followed this with sub-specialty fellowship training at the Institute for Reconstructive Plastic Surgery located at New York University Medical Center and then completed his training at Stanford University with a fellowship in Craniofacial and Maxillofacial Surgery.

David Kahn research interests include cosmetic and reconstructive facial surgery, cosmetic and reconstructive breast surgery, rhinoplasty, face lift, cleft lip and palate and cosmetic surgery.

Dr. Elizabeth Barrett-Connor’s research focuses primarily on gender differences in chronic diseases and healthy aging. Over 40 years ago, she established the Rancho Bernardo Study (RBS), which remains one of the longest continuously running extramural program funded by the NIH in the United States. RBS continues to provide research training and publications on topics ranging from heart disease, diabetes, hypertension, osteoporosis, and arthritis, to mental health, memory loss, socio-economic factors related to health, health-related habits, to diverse biologic markers. Dr. Barrett-Connor has led numerous clinical trials related to women’s health – particularly studies of Hormone Replacement Therapy. She currently serves as the co-Principal Investigator for a number of multi-site NIH funded studies, including the Diabetes Prevention Program, the Diabetes Prevention Outcomes Study, MrOs (a study of osteoporosis in men), The T-Trial (investigating testosterone and men’s health), and is a co-investigator on a T-Trial ancillary study, and a study on alcohol and nutrition on cognition and brain structure in aging. Her work has received numerous awards, most recently, the Population Science Award from the American Heart Association (AHA, 2011), the Endocrine Society Mentoring Award (2012), the Women in Epidemiology, Epidemiology and Prevention Mentoring Award (EPI/NPAM, 2013), and the Distinguished Fellowship Award from the International Academy of Cardiology (2013). Dr. Barrett-Connor has published over 1,000 manuscripts in peer-reviewed journals. Until this past year, for 40 years she served as the UC School of Medicine’s Chief of the Division of Epidemiology.

Elizabeth Barrett-Connor’s research concerns healthy aging with a particular focus on gender differences and women's health. Her pioneering work spans many areas including cardiovascular disease, diabetes, cancer, osteoporosis, memory loss and exogenous and endogenous hormones. She is author of more than 700 publications. Epidemiologic studies of normative aging and diseases of adult life, particularly cardiovascular disease, cancer, diabetes, osteoporosis, menopause, memory loss, and lifestyle (diet, exercise, etc.). Both observational/analytic studies of an established cohort (Rancho Bernardo) and clinical trials are ongoing.

Dr. Jean J. Latimer currently is an Associate Professor in the Department of Pharmaceutical Sciences at Nova Southeastern University, USA. Dr. Jean J. Latimer completed his PhD in Department of Molecular and Cellular Biology at University of New York at Buffalo, NY. Dr. Jean J. Latimer completed his Postdoctoral Fellowship in Laboratory of Radiobiology and Environmental Health at University of California, San Francisco, USA.

Dr. Jean Latimer research involves human breast cancer etiology. She is exploring the loss of DNA repair mechanisms in early stage breast cancer as a source of genomic instability. In addition Dr. Jean Latimer is interested in the unique vulnerability of human breast tissue for DNA damage which originates from environmental causes.